相似文献
1
Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy.
Mediators Inflamm. 2018 Sep 27;2018:6238978. doi: 10.1155/2018/6238978. eCollection 2018.
2
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.
Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):531-540. doi: 10.1080/17474124.2019.1599284. Epub 2019 Apr 3.
3
HIV and inflammation: mechanisms and consequences.
Curr HIV/AIDS Rep. 2012 Jun;9(2):139-47. doi: 10.1007/s11904-012-0118-8.
4
Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment.
Front Immunol. 2021 Jun 18;12:670566. doi: 10.3389/fimmu.2021.670566. eCollection 2021.
5
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
Curr HIV/AIDS Rep. 2016 Feb;13(1):10-9. doi: 10.1007/s11904-016-0297-9.
6
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.
Drugs. 2016 Apr;76(5):533-49. doi: 10.1007/s40265-016-0546-7.
7
Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy.
Front Immunol. 2020 Oct 9;11:583934. doi: 10.3389/fimmu.2020.583934. eCollection 2020.
8
HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4250-4259. doi: 10.1210/jc.2017-01334.
9
Liver disease in the HIV-infected individual.
Clin Gastroenterol Hepatol. 2010 Dec;8(12):1002-12. doi: 10.1016/j.cgh.2010.08.024. Epub 2010 Sep 17.
10
Research Progress on the Relationship between the NLRP3 Inflammasome and Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy.
Comput Math Methods Med. 2022 Mar 10;2022:3179200. doi: 10.1155/2022/3179200. eCollection 2022.
引用本文的文献
1
Innate immune dysfunction and persistent activation in South African HIV elite controllers.
Front Immunol. 2025 Aug 27;16:1603436. doi: 10.3389/fimmu.2025.1603436. eCollection 2025.
2
HIV, Inflammation, and Immunometabolism: A Model of the Inflammatory Theory of Disease.
Viruses. 2025 Jun 11;17(6):839. doi: 10.3390/v17060839.
3
The Tryptophan-Kynurenine pathway in people living with HIV: a systematic review.
Infection. 2025 May 31. doi: 10.1007/s15010-025-02557-1.
4
Phenotypic characterization of NK cells in 5-year-old children exposed to maternal HIV and antiretroviral therapy in early-life.
BMC Immunol. 2024 Dec 19;25(1):82. doi: 10.1186/s12865-024-00674-4.
5
The impacts of tobacco and nicotine on HIV-1 infection, inflammation, and the blood-brain barrier in the central nervous system.
Front Pharmacol. 2024 Oct 28;15:1477845. doi: 10.3389/fphar.2024.1477845. eCollection 2024.
6
HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis.
Front Microbiol. 2024 Aug 2;15:1428239. doi: 10.3389/fmicb.2024.1428239. eCollection 2024.
7
Potential Advantages of a Well-balanced Nutrition Regimen for People Living with Human Immunodeficiency Virus Type -1.
J AIDS HIV Treat. 2024;6(1):11-27. doi: 10.33696/aids.6.048.
8
HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps.
Circ Res. 2024 May 24;134(11):e150-e175. doi: 10.1161/CIRCRESAHA.124.323979. Epub 2024 May 23.
9
Role of aryl hydrocarbon receptors in infection and inflammation.
Front Immunol. 2024 Apr 12;15:1367734. doi: 10.3389/fimmu.2024.1367734. eCollection 2024.
10
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile.
Open Forum Infect Dis. 2024 Mar 1;11(4):ofae112. doi: 10.1093/ofid/ofae112. eCollection 2024 Apr.
本文引用的文献
1
Metabolites predict cardiovascular disease events in persons living with HIV: a pilot case-control study.
Metabolomics. 2018 Mar;14(3). doi: 10.1007/s11306-018-1318-z. Epub 2018 Jan 31.
2
Polymorphism rs1385129 Within Glut1 Gene Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals.
Front Immunol. 2018 May 17;9:900. doi: 10.3389/fimmu.2018.00900. eCollection 2018.
3
Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):135-140. doi: 10.1097/QAI.0000000000001768.
4
Antiretroviral therapy potentiates high-fat diet induced obesity and glucose intolerance.
Mol Metab. 2018 Jun;12:48-61. doi: 10.1016/j.molmet.2018.04.006. Epub 2018 Apr 20.
5
Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy.
Atherosclerosis. 2018 Jun;273:28-36. doi: 10.1016/j.atherosclerosis.2018.04.008. Epub 2018 Apr 9.
6
Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
AIDS Res Hum Retroviruses. 2018 Jun;34(6):536-543. doi: 10.1089/AID.2017.0314. Epub 2018 May 2.
7
Human immunodeficiency virus Tat impairs mitochondrial fission in neurons.
Cell Death Discov. 2018 Feb 2;4:8. doi: 10.1038/s41420-017-0013-6. eCollection 2018 Dec.
8
Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.
Viruses. 2018 Mar 7;10(3):114. doi: 10.3390/v10030114.
9
A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation.
Front Immunol. 2018 Feb 5;9:141. doi: 10.3389/fimmu.2018.00141. eCollection 2018.
10
Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging.
F1000Res. 2018 Jan 30;7:125. doi: 10.12688/f1000research.11881.1. eCollection 2018.
Zotero 插件